Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.20 +0.00 (+1.92%)
As of: Oct 21, 2026 · 2:34 PM EDT

Vistagen Therapeutics (VTGN) Non-Current Debt (2016 - 2026)

Updated

Vistagen Therapeutics (VTGN) posted Non-Current Debt of $87,300 for fiscal Q2 2021 (quarter ended Sep 30, 2020), down 30.0% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Non-Current Debt (2016 - 2026) Analysis & Trends

At the end of FY2016 (ended Mar 31, 2016), Vistagen Therapeutics' Non-Current Debt came in at $27,200.

  • The fiscal Q2 2021 figure stands as the lowest quarterly Non-Current Debt since fiscal Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,135.99 Bn 1,104.58 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 616.90 Bn 535.42 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.56 Bn 474.68 Bn 12.70 Bn 62.48 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.45 Bn 235.13 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.48 Bn 191.88 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.56 Bn 164.76 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 60.50 Bn
10 Vistagen Therapeutics 8.66 Mn -207.41 Mn - -96,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Jun 30, 2023 784,200.00
Mar 31, 2023 105,300.00
Dec 31, 2022 419,100.00
Sep 30, 2022 730,000.00
Jun 30, 2022 1.04 Mn
Sep 30, 2020 87,300.00
Jun 30, 2020 124,700.00
Mar 31, 2020 56,500.00
Mar 31, 2019 57,300.00
Mar 31, 2018 53,900.00
Mar 31, 2017 54,800.00
Mar 31, 2016 98,000.00
API Access

Vistagen Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=VTGN&period=max&api_key=YOUR_API_KEY